Valuation: 111, Inc.

Market Cap 215M 32.06M 27.96M 26.33M 23.98M 44.96M 3.07B 45.02M 315M 122M 1.56B 120M 118M 5.05B P/E 2024
-6.03x
P/E 2025 -2.35x
Enterprise Value -136M -20.25M -17.66M -16.63M -15.15M -28.4M -1.94B -28.43M -199M -76.77M -988M -76.08M -74.39M -3.19B EV / Sales 2024
0.01x
EV / Sales 2025 -0.02x
Free-Float
39.41%
Yield 2024 *
-
Yield 2025 -
17/09 Huadeng Tech BioArray Ventures Ltd, Gang Yu, co-founder and co-chairman of 111, Inc, and the Junling Liu, co-founder, co-chairman and chief executive officer of 111, Inc. submitted an unsolicited preliminary non-binding proposal letter to acquire remaining 57.79% stake in 111, Inc. (NasdaqGM:YI) for $23 million. CI
17/09 111, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
17/09 111 Receives Going-Private Proposal From Co-Founders, Huadeng Tech BioArray Ventures MT
17/09 Alerts wrongly tagged to short VIX futures ETFs withdrawn RE
10/09 Asian Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading MT
09/09 Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading MT
01/09 Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading MT
26/08 Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading MT
18/08 Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading MT
08/07 Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading MT
13/06 Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Marginally Lower for Week MT
06/06 Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading MT
04/06 111, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
1 day+1.25%
1 week+4.14%
Current month+10.45%
1 month+2.10%
3 months-17.35%
6 months-46.79%
Current year+42.38%
1 week 3.28
Extreme 3.28
4.08
1 month 2.68
Extreme 2.68
4.08
Current year 2.48
Extreme 2.48
11.17
1 year 2.48
Extreme 2.48
11.17
3 years 2.48
Extreme 2.48
26.8
5 years 2.48
Extreme 2.48
64.7
10 years 2.48
Extreme 2.48
458.8
Manager TitleAgeSince
Chief Executive Officer 61 01/05/2013
Director of Finance/CFO 56 04/11/2024
Director TitleAgeSince
Chairman 66 01/05/2013
Chairman 61 01/05/2013
Director/Board Member 55 01/09/2018
Date Insider Type Main position Quantity % Market Cap. Importance
27/5/26 Sell

Director

-70,440 0.0745%
27/5/26 Sell

Director

-70,440 0.0745%
27/5/26 Sell

Chief Financial Officer

-3,400 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%+4.14%-30.17%-85.24% 32.06M
+2.22%+5.97%-28.90%+37.62% 288B
+7.33%+3.01%-10.03%+156.83% 177B
+0.50%-0.11%-38.75%-13.97% 113B
+1.85%-4.20%-25.77%+40.76% 92.29B
-1.08%-2.07%-29.55%-39.40% 58.21B
-3.17%-0.63%+18.87%+146.58% 48.19B
-1.26%-8.89%-36.95%-32.99% 26.77B
+0.60%-0.39%-29.60%+32.81% 15.5B
+1.54%+0.48%-31.99%-13.79% 6.92B
Average +1.28%-0.20%-24.29%+22.92% 82.59B
Weighted average by Cap. +2.79%+1.82%-23.40%+54.65%

Financials

2024 2025
Net sales 14.4B 2.15B 1.88B 1.77B 1.61B 3.02B 206B 3.02B 21.15B 8.15B 105B 8.08B 7.9B 339B 12.56B 1.87B 1.63B 1.54B 1.4B 2.63B 180B 2.63B 18.44B 7.11B 91.5B 7.04B 6.89B 295B
Net income -64.74M -9.67M -8.43M -7.94M -7.23M -13.56M -926M -13.57M -95.08M -36.65M -472M -36.32M -35.51M -1.52B -66.39M -9.91M -8.64M -8.14M -7.41M -13.9M -950M -13.92M -97.5M -37.58M -484M -37.24M -36.42M -1.56B
Net Debt -225M -33.65M -29.34M -27.63M -25.17M -47.19M -3.22B -47.24M -331M -128M -1.64B -126M -124M -5.3B -350M -52.32M -45.62M -42.96M -39.13M -73.36M -5.01B -73.45M -515M -198M -2.55B -197M -192M -8.24B
Logo 111, Inc.
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
Employees
1,063
Date Price Change Volume
21/09/26 USD 3.645 +1.25% 26,929
18/09/26 USD 3.600 +1.69% 14,259
17/09/26 USD 3.540 +4.73% 81,197
16/09/26 USD 3.380 -3.15% 11,126
15/09/26 USD 3.490 -0.29% 10,017

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!